Application note: Validation of identified through AI
Targets for drug discovery can be identified with AI but require validation in vitro. Here’s how this can be done, using hiPSC technology.
List view / Grid view
Targets for drug discovery can be identified with AI but require validation in vitro. Here’s how this can be done, using hiPSC technology.
The development of a Parkinson’s disease model, using hiPSC-derived neural cells, to assess alpha-synuclein pre-formed fibril-induced toxicity.
This whitepaper describes the automated culturing of hiPSC-derived cells for high-throughput phenotypic screening, using validated phenotypic assays.
Mass production with iPSCs: how Ncardia has pushed the boundaries with high-throughput iPSC research.
Neuroinflammation study by combining human iPSC-derived astrocytes and HTRF.
Controlled manufacturing of hiPSC-derived cardiomyocytes in stirred-tank bioreactors enabling high-throughput phenotypic screening.
This Ncardia company presentation will explain how human stem cell technology offers a solution for drug screening as well as cell therapy projects.
Effective drug discovery and development greatly relies on the availability of predictive pre-clinical models.